MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment

MLA

Patrizia Garbati, et al. “MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment.” Biomedicines, vol. 8, no. 11, Nov. 2020, p. 471. EBSCOhost, https://doi.org/10.3390/biomedicines8110471.

APA

Patrizia Garbati, Raffaella Barbieri, Davide Cangelosi, Carlo Zanon, Delfina Costa, Alessandra Eva, Stefano Thellung, Matilde Calderoni, Francesca Baldini, Gian Paolo Tonini, Paola Modesto, Tullio Florio, & Aldo Pagano. (2020). MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment. Biomedicines, 8(11), 471. https://doi.org/10.3390/biomedicines8110471

Chicago

Patrizia Garbati, Raffaella Barbieri, Davide Cangelosi, Carlo Zanon, Delfina Costa, Alessandra Eva, Stefano Thellung, et al. 2020. “MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment.” Biomedicines 8 (11): 471. doi:10.3390/biomedicines8110471.